-
1
-
-
0014366073
-
Humoral factors in massive pulmonary embolism: an experimental study
-
Gurewich V., Cohen M.L., and Thomas D.P. Humoral factors in massive pulmonary embolism: an experimental study. Am Heart J 76 (1968) 784-794
-
(1968)
Am Heart J
, vol.76
, pp. 784-794
-
-
Gurewich, V.1
Cohen, M.L.2
Thomas, D.P.3
-
2
-
-
0024215724
-
Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension
-
Priebe H.J. Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension. Am J Physiol 255 (1988) H1232-H1239
-
(1988)
Am J Physiol
, vol.255
-
-
Priebe, H.J.1
-
3
-
-
20044372707
-
Effects of the endothelin receptor antagonist bosentan on hemodynamics, symptoms and functional capacity in Japanese patients with severe pulmonary hypertension
-
Sasayama S., Kunieda T., Tomoike H., Matsuzaki M., Shirato K., Kuriyama T., et al. Effects of the endothelin receptor antagonist bosentan on hemodynamics, symptoms and functional capacity in Japanese patients with severe pulmonary hypertension. Circ J 69 (2005) 131-137
-
(2005)
Circ J
, vol.69
, pp. 131-137
-
-
Sasayama, S.1
Kunieda, T.2
Tomoike, H.3
Matsuzaki, M.4
Shirato, K.5
Kuriyama, T.6
-
4
-
-
56249104093
-
Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension
-
Vizza C.D., Letizia C., Petramala L., Badagliacca R., Poscia R., Zepponi E., et al. Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension. Regul Pept 151 1-3 (2008) 48-53
-
(2008)
Regul Pept
, vol.151
, Issue.1-3
, pp. 48-53
-
-
Vizza, C.D.1
Letizia, C.2
Petramala, L.3
Badagliacca, R.4
Poscia, R.5
Zepponi, E.6
-
5
-
-
0038639717
-
Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism
-
Battistini B. Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism. Can J Physiol Pharm 81 (2003) 555-569
-
(2003)
Can J Physiol Pharm
, vol.81
, pp. 555-569
-
-
Battistini, B.1
-
6
-
-
0030969346
-
Endothelin abnormalities in patients with pulmonary embolism
-
Sofia M., Faraone S., Alifano M., Micco A., Albisinni R., Maniscalco M., et al. Endothelin abnormalities in patients with pulmonary embolism. Chest 111 (1997) 544-549
-
(1997)
Chest
, vol.111
, pp. 544-549
-
-
Sofia, M.1
Faraone, S.2
Alifano, M.3
Micco, A.4
Albisinni, R.5
Maniscalco, M.6
-
7
-
-
33846856937
-
Endothelin receptor blockade does not improve hypoxemia following acute pulmonary thromboembolism
-
Tsang J.Y., Lamm W.J., Neradilek B., Polissar N.L., and Hlastala M.P. Endothelin receptor blockade does not improve hypoxemia following acute pulmonary thromboembolism. J Appl Physiol 102 (2007) 762-771
-
(2007)
J Appl Physiol
, vol.102
, pp. 762-771
-
-
Tsang, J.Y.1
Lamm, W.J.2
Neradilek, B.3
Polissar, N.L.4
Hlastala, M.P.5
-
8
-
-
52449110713
-
Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
-
Torbicki A., Perrier A., Konstantinides S., Agnelli G., Galie N., Pruszczyk P., et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29 18 (2008) 2276-2315
-
(2008)
Eur Heart J
, vol.29
, Issue.18
, pp. 2276-2315
-
-
Torbicki, A.1
Perrier, A.2
Konstantinides, S.3
Agnelli, G.4
Galie, N.5
Pruszczyk, P.6
-
9
-
-
33748998458
-
Pulmonary arterial hypertension
-
McLaughlin V.V., and McGoon M.D. Pulmonary arterial hypertension. Circulation 114 (2006) 1417-1431
-
(2006)
Circulation
, vol.114
, pp. 1417-1431
-
-
McLaughlin, V.V.1
McGoon, M.D.2
-
10
-
-
0033735144
-
Biphasic release of immunoreactive endothelins following acute pulmonary thromboembolism in pigs
-
Tsang J., Battistini B., Dussault P., Stewart K., and Qayumi K.A. Biphasic release of immunoreactive endothelins following acute pulmonary thromboembolism in pigs. J Cardiovasc Pharmacol 36 (2000) S221-S224
-
(2000)
J Cardiovasc Pharmacol
, vol.36
-
-
Tsang, J.1
Battistini, B.2
Dussault, P.3
Stewart, K.4
Qayumi, K.A.5
-
11
-
-
0027432278
-
Coagulation in vivo microcirculation and in vitro caused by endothelin-1
-
Halim A., Kanayama N., el Maradny E., Maehara K., and Terao T. Coagulation in vivo microcirculation and in vitro caused by endothelin-1. Thromb Res 72 (1993) 203-209
-
(1993)
Thromb Res
, vol.72
, pp. 203-209
-
-
Halim, A.1
Kanayama, N.2
el Maradny, E.3
Maehara, K.4
Terao, T.5
-
12
-
-
0028021371
-
Endothelin-1 increased immunoreactive von Willebrand factor in endothelial cells and induced micro thrombosis in rats
-
Halim A., Kanayama N., el Maradny E., Maehara K., Masahiko H., and Terao T. Endothelin-1 increased immunoreactive von Willebrand factor in endothelial cells and induced micro thrombosis in rats. Thromb Res 76 (1994) 71-78
-
(1994)
Thromb Res
, vol.76
, pp. 71-78
-
-
Halim, A.1
Kanayama, N.2
el Maradny, E.3
Maehara, K.4
Masahiko, H.5
Terao, T.6
-
13
-
-
0028850818
-
In vitro effect of endothelin-1 on collagen, and ADP-induced aggregation in human whole blood and platelet rich plasma
-
Knofler R., Urano T., Malyszko J., Takada Y., and Takada A. In vitro effect of endothelin-1 on collagen, and ADP-induced aggregation in human whole blood and platelet rich plasma. Thromb Res 77 (1995) 69-78
-
(1995)
Thromb Res
, vol.77
, pp. 69-78
-
-
Knofler, R.1
Urano, T.2
Malyszko, J.3
Takada, Y.4
Takada, A.5
-
14
-
-
0028881583
-
Endothelin-1 in pulmonary hypertension associated with high-altitude exposure
-
Goerre S., Wenk M., Bartsch P., Luscher T.F., Niroomand F., Hohenhaus E., et al. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 91 (1995) 359-364
-
(1995)
Circulation
, vol.91
, pp. 359-364
-
-
Goerre, S.1
Wenk, M.2
Bartsch, P.3
Luscher, T.F.4
Niroomand, F.5
Hohenhaus, E.6
|